CRIS Current Research Information System

BEDINI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.676
EU - Europa 3.142
AS - Asia 2.772
AF - Africa 428
SA - Sud America 199
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.221
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.639
SG - Singapore 952
CN - Cina 886
GB - Regno Unito 798
IT - Italia 732
DE - Germania 401
VN - Vietnam 347
SE - Svezia 271
HK - Hong Kong 208
RU - Federazione Russa 188
IN - India 174
TG - Togo 163
UA - Ucraina 144
BR - Brasile 142
FR - Francia 123
IE - Irlanda 120
CI - Costa d'Avorio 85
BG - Bulgaria 84
NG - Nigeria 81
ZA - Sudafrica 72
EE - Estonia 63
NL - Olanda 51
JP - Giappone 49
JO - Giordania 42
FI - Finlandia 29
AR - Argentina 26
CH - Svizzera 26
CA - Canada 22
HR - Croazia 21
ID - Indonesia 20
KR - Corea 20
ES - Italia 19
SC - Seychelles 19
TR - Turchia 17
IR - Iran 15
BE - Belgio 14
MX - Messico 12
PL - Polonia 11
AT - Austria 9
GR - Grecia 9
LB - Libano 8
BD - Bangladesh 7
CL - Cile 7
LT - Lituania 7
CO - Colombia 6
PK - Pakistan 6
PE - Perù 5
RO - Romania 5
EC - Ecuador 4
LU - Lussemburgo 4
MA - Marocco 4
AE - Emirati Arabi Uniti 3
DO - Repubblica Dominicana 3
GY - Guiana 3
IL - Israele 3
KZ - Kazakistan 3
PY - Paraguay 3
AU - Australia 2
DK - Danimarca 2
KE - Kenya 2
MY - Malesia 2
TH - Thailandia 2
UZ - Uzbekistan 2
VE - Venezuela 2
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CY - Cipro 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
EU - Europa 1
HU - Ungheria 1
IQ - Iraq 1
KI - Kiribati 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MD - Moldavia 1
MK - Macedonia 1
NO - Norvegia 1
NP - Nepal 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
UY - Uruguay 1
Totale 10.221
Salva come PNG Salva come JPEG
Città #
Southend 699
Singapore 599
Fairfield 340
Chandler 312
Ashburn 296
Santa Clara 294
Bologna 210
Hong Kong 207
Princeton 185
Lomé 163
Wilmington 161
Woodbridge 156
Seattle 144
Cambridge 141
Beijing 137
Houston 132
Ann Arbor 127
Dublin 117
Dong Ket 102
Boardman 92
Jacksonville 86
Abidjan 85
Sofia 84
Nanjing 83
Abeokuta 81
Westminster 77
Padova 75
Milan 61
Ho Chi Minh City 58
Medford 50
Jinan 49
Los Angeles 49
Berlin 48
Tokyo 48
Saint Petersburg 46
Hefei 45
Shenyang 43
Amman 42
Hanoi 36
Redondo Beach 35
Buffalo 31
Hebei 31
San Diego 30
Dallas 29
Nanchang 29
New York 29
Tianjin 28
Redmond 25
Changsha 23
Frankfurt am Main 23
Munich 22
Mülheim 22
Shanghai 22
Bremen 20
Guangzhou 20
Seoul 18
Helsinki 17
Norwalk 17
Chicago 16
Falls Church 15
Zhengzhou 15
Bern 14
Haikou 14
Yubileyny 14
Des Moines 13
London 13
Moscow 13
Redwood City 13
São Paulo 13
Brussels 12
Hangzhou 11
Jakarta 11
Nuremberg 11
Turin 11
Turku 11
Falkenstein 10
Jiaxing 10
Mahé 10
Toronto 10
Wuhan 10
Ningbo 9
Parma 9
Phoenix 9
Shenzhen 9
Taizhou 9
Bühl 8
Denver 8
Olalla 8
Paris 8
Ardabil 7
Istanbul 7
San Venanzo 7
Shijiazhuang 7
Taiyuan 7
Warsaw 7
Brooklyn 6
Derby 6
Manchester 6
Modena 6
San Francisco 6
Totale 6.650
Salva come PNG Salva come JPEG
Nome #
T cell receptor/CD28-mediated activation of human T lymphocytes induces expression of functional {micro}-opioid receptors. 237
Leukocyte Integrin Antagonists as a Novel Option to Treat Dry Age-Related Macular Degeneration 231
Chitosan-based Polyelectrolyte Complexes for Nasal Drug Delivery 230
Constraining Endomorphin-1 by β,α-Hybrid Dipeptide/Heterocycle Scaffolds: Identification of a Novel κ-Opioid Receptor Selective Partial Agonist 222
Ligand Based Approach to L-Type Calcium Channel by Imidazo[2,1-b]thiazole-1,4-Dihydropyridines: from Heart Activity to Brain Affinity 205
Therapeutic Targeting of Eosinophil Adhesion and Accumulation in Allergic Conjunctivitis 197
Diphenidol-related diamines as novel muscarinic M4 receptor antagonists 194
REST is up-regulated by epidermal growth factor in HeLa cells and inhibits apoptosis by influencing histone H3 acetylation 191
A novel family of minimalist opioid peptides deprived of the classic pharmacophores 190
DS-70, a novel and potent α4 integrin antagonist, is an effective treatment for experimental allergic conjunctivitis in guinea pigs 190
Transcription factor REST negatively influences the protein kinase C-dependent up-regulation of human mu-opioid receptor gene transcription 188
Nociceptin/orphanin FQ antagonizes lipopolysaccharide-stimulated proliferation, migration and inflammatory signaling in human glioblastoma U87 cells 185
Ac-D-Trp-PheNH2 AND Ac-D-Trp-Phe-GlyNH2 - A NEW CLASS OF UNUSUAL OPIOID PEPTIDES 182
Antiangiogenic Effect of Dual/Selective α5β1/αvβ3 Integrin Antagonists Designed on Partially Modified Retro-Inverso Cyclotetrapeptide Mimetics 177
Functional Selectivity and Antinociceptive Effects of a Novel KOPr Agonist 173
Imidazo[2,1-b]thiazole System: a Scaffold Endowing Dihydropyridines With Selective Cardiodepressant Activity 168
A Blocking Group Scan Using a Spherical Organometallic Complex Identifies an Unprecedented Binding Mode with Potent Activity In Vitro and In Vivo for the Opioid Peptide Dermorphin 165
Plasma nociceptin/orphanin FQ levels in response to the hyperventilation test in healthy subjects. 161
Opioid Activity Profiles of Oversimplified Peptides Lacking in the Protonable N-Terminus 157
The Inverse Type II β-Turn on D-Trp-Phe, a Pharmacophoric Motif for MOR Agonists. 155
DESIGN AND SYNTHESIS OF OPIOID PEPTIDE ANALOGUES AND MIMETICS 155
Contribution of alpha4beta1 integrin to the antiallergic effect of levocabastine 154
Plasma nociceptin/orphanin FQ levels rise after spontaneous episodes of angina, but not during induced myocardial ischemia 153
Investigation of the Interaction Between the Atypical Agonist c[YpwFG] and MOR 152
A new generation of opioid peptidomimetics acting as central and/or peripheral analgesics 147
Prodynorphin-derived peptides 146
Eosinophil as a cellular target of the ocular anti-allergic action of mapracorat, a novel selective glucocorticoid receptor agonist 146
Mu opioid receptor stimulation activates c-Jun N-terminal kinase 2 by distinct arrestin-dependent and independent mechanisms 146
mu-opioid receptor (MOR) expression and opioid-mediated intracellular signalling are altered in glial cells exposed to TNF-alpha 142
Role of nociceptin/orphanin FQ in thermoregulation 141
Bioluminescence resonance energy transfer (BRET) to detect the interactions between kappa opioid receptor and non visual arrestins. 136
Identification of c[D-Trp-Phe-β-Ala-β-Ala], the First κ-Opioid Receptor-Specific Negative Allosteric Modulator 135
Protective and worsening peripheral nociceptin/orphanin FQ receptor-mediated effect in a rat model of experimental colitis 132
Analysis of promoter regions regulating basal and interleukin-4-inducible expression of the human CB1 receptor gene in T lymphocytes 131
Versatile Picklocks to Access All Opioid Receptors: Tuning the Selectivity and Functional Profile of the Cyclotetrapeptide c[Phe- d -Pro-Phe-Trp] (CJ-15,208) 129
Transcriptional activation of human mu-opioid receptor gene by insulin-like growth factor-I in neuronal cells is modulated by the transcription factor REST 126
DETERMINATION OF THE BIOLOGICALLY ACTIVE STRUCTURE OF THE ATYPICAL MOR-LIGAND c[D-Asp-1-amide-beta-Ala-D-Trp-Phe] AND ANALOGUES BY NMR AND MOLECULAR DOCKING 125
Renilla luciferase reporter assay to study 3'UTR-driven posttranscriptional regulations of OPRM1. 123
Inhibition of Toll-like Receptor 4 (TLR4)-induced NF-kB activation by NOP is lost in human glioblastoma cells chronically exposed to LPS. 114
Interactions between atypical opioid agonists and MOR 114
Development and characterization of novel EphB1 receptor antagonists. 111
Investigation on MOR receptor activation by atypical mechanisms 110
Expression of the transcription factor REST at different stages of neuronal differentiation: contribution of PKC and WNT/-catenin signaling 109
Biphasic modulation of mu-opoid receptor (MOR) transcription by nociceptin in neuroblastoma cells co-expressing MOR and NOP receptors 108
Development and characterization of novel EphB1 receptor antagonists. 108
Development and characterization of Endomorphin-1 analogues as novel potential analgesic drugs. 107
Novel Antagonist targeting EphB1 receptor 105
Identification of a new, functional cross-talk between EphB1 receptor and mu opioid receptor 104
Innovative opioid peptides and biased agonism: Novel avenues for more effective and safer analgesics to treat chronic pain 103
Reactive oxygen species (ROS) generation is stimulated by opioid receptor activation through phosphorylated c-Jun N-terminal kinase and inhibited by p38 mitogen-activated protein kinase (MAPK) activation 101
Synthesis of tripeptides containing D-Trp substituted at indole ring, and assessment of MOR affinity and in vivo central antinociception. 100
Molecular Mechanisms Mediating Nociceptin/Orphanin FQ Receptor Signaling, Desensitization and Internalization. 100
Bioluminescence resonance energy transfer (bret) to detect the interactions between kappa opioid receptor and nonvisual arrestins 100
Development and characterization of novel EphB1 receptor antagonists 96
null 93
Opioid activity profiles of peptides containing overlapping portions of CJ-15,208 and CycloEM, and identification of the bioactive conformations 92
The ocular antiallergic action of mapracorat, a novel selective glucocorticoid receptor agonist, involves eosinophils and mast cells: evidence from human cells in vitro and an animal model 92
Identification of a novel, functional cross-talk between EphB1 receptor and mu opioid receptor. 92
Novel Antagonist targeting EphB1 receptor 92
TRYptophan-COntaining Non-Cationizable Opioid PeptideS (TRYCONCOPS): A new paradigm for opioid peptides 89
Protein Kinase C-dependent up-regulation of human mu-opioid receptor gene (OPRM1) transcription is negatively influenced by the transcription factor REST 87
Genomic and non-genomic effects of anabolic steroids on opioid receptor gene expression in neuronal cells 87
Identification of a novel, functional cross-talk between EphB1 receptor and mu opioid receptor 87
PKC modulation of mu-opioid receptor gene (OPRM1) transcription is influenced by the transcription factor REST 85
PKC regulates MOR transcriptional activity: role of the proximal region of the promoter 85
At the cross-roads between immune system and nervous system: expression and intracellular signalling of opioid and opioid-related receptors in human glial cells exposed to pro-inflammatory stimuli. 85
Insulin-like Growth Factor I (IGF-I) induces human mu opioid receptor (MOR) expression in differentiated neurons: role of transcription factors REST and STAT3 84
TNF-alpha-induced MOR up-regulation in human glioblastoma cells is coupled to a loss of MOR-activated signalling to intracellular effectors 84
Ocular anti-allergic action of mapracorat, a novel selective glucocorticoid receptor agonist, involves eosinophil's apoptosis. 84
Neuron-Glia cross-talk: pharmacological and biotechnological strategies to identify novel therapeutic targets for neuropatic pain 83
Insulin-like Growth Factor I (IGF-I) modulates hMOR transcription in neuronal cells: role of STAT3 80
Pro-inflammatory stimuli increase mu-opioid receptor (MOR) number on cell surface of human glioblastoma cells but hamper opioid agonist-induced intracellular signaling. G-protein-coupled-receptors: from structural insights to functional mechanisms 80
Quantitative Systems Pharmacology and Biased Agonism at Opioid Receptors: A Potential Avenue for Improved Analgesics 79
Endomorphin-1 analogues as novel and highly selective MOPr agonists: design and characterization of innovative analgesic drugs 77
Renilla luciferase reporter assay to study 3′-utr-driven posttranscriptional regulation of oprm1 75
Expression of the Cannabinoid Receptor type I in T-cells and its regulation by cannabinoids and IL-4 73
Regulation of mu-opioid receptor by gene transcription 72
Peripheral antinociceptive effects of the cyclic endomorphin-1 analog c[YpwFG] in a mouse visceral pain model 70
Trypoids, a novel group of mu-opioid receptor-selective di- and tri-peptides: design and characterization of novel analgesics 69
Mechanisms of morphine-induced suppression of T-cell signaling. 69
Functional cross-talk between TLR4 and NOPr in human glial cells. 67
Mapracorat, a selective glucocorticoid receptor agonist, causes apoptosis of eosinophils infiltrating the conjunctiva in late phase experimental ocular allergy 60
null 54
The quest for more effective analgesics with reduced abuse liability and fewer adverse effects: Promises, pitfalls, and future perspectives of biased agonists at opioid receptors 50
Targeting α4β1 integrin: from cyclic to linear ligands, effects of chemical modifications 13
Totale 10.396
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.119
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.119
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021563 0 0 0 0 0 41 42 57 70 46 64 243
2021/20221.472 164 80 66 61 147 73 64 144 63 88 213 309
2022/20231.667 177 310 75 184 148 128 81 85 282 40 96 61
2023/2024513 37 74 23 35 34 133 40 29 28 23 35 22
2024/20251.857 57 294 190 96 402 107 184 59 7 75 48 338
2025/20261.639 184 264 306 286 428 171 0 0 0 0 0 0
Totale 10.396